DFCO
Dalrada Technology Group Inc.0.0448
-0.0002-0.44%
Dec 5, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
5.38MP/E (TTM)
-Basic EPS (TTM)
-0.22Dividend Yield
0%Recent Filings
10-Q
Q1 FY2026 results
Dalrada's Q1 FY2026 total revenues fell 32% y/y to $4.1M, with Genefic down sharply while Climate Technology doubled to $1.7M on Bothof construction wins; gross profit shrank to $560K from $1.2M. Operating loss narrowed to $5.3M from $5.7M, yet net loss widened to $6.1M versus $6.8M due to $733K interest expense. Cash burned $4.2M in operations but financing delivered $4.5M, lifting cash to $489K amid $12.6M equity deficit. Grand Entrances closed Aug 2024 for $100 cash plus $211K contingent, adding $185K goodwill. Debt totals $12.4M including related-party notes; EIDL in technical default. Ongoing litigation poses collection risks.
10-K
FY2025 results
Dalrada Financial Corporation posted FY2025 revenue of $20.3M, edging up 2.3% y/y from $19.8M, but net loss narrowed to $24.7M from $29.2M amid cost centralization, though a $2.7M goodwill impairment in Precision Manufacturing dragged results. Genefic revenue dipped 21.1% y/y to $10.4M on a pharmacy model shift, yet Climate Technology surged 188% to $8.1M fueled by construction gains, while Precision cratered 81.7% to $0.4M after losing a key client. Q4 momentum faltered with ongoing DepTec project delays and heat pump commercialization hurdles, but Bothof Brothers' contracts and pharmacy ramp-up hint at stabilization. Cash burned $18.0M in operations, offset by $18.8M in financing, leaving $0.5M on hand amid $8.9M debt; no dividends or buybacks occurred. No annual guidance disclosed. Ongoing litigation risks could further erode quarterly cash flows.
10-Q
Q3 FY2025 results
Dalrada Financial's Q3 FY2025 revenues climbed 33.5% y/y to $4.6M, fueled by a 528% surge in Dalrada Climate Technology from Bothof Brothers' construction wins, though Genefic dipped 40% on softer pharmacy sales. Gross profit swung to $1.4M from a $1.7M loss, lifting margins to 31%, yet operating expenses held steady at $5.3M, driving a $3.9M operating loss—better than last year's $8.7M hole. Net loss narrowed to $4.2M or $(0.05) per diluted share on 92.9M shares, with the gap to operating loss tied to $298K interest expense. Cash dwindled to $99K amid $6.1M operating burn, offset by $6.2M financing inflows including related-party notes; free cash flow not disclosed in the 10-Q. Acquired Grand Entrances in August 2024 for $100 cash plus $211K contingent consideration, adding $185K goodwill to integrate doors into construction. Liquidity strains persist with a $15.5M working capital deficit and going concern doubts. Ongoing litigation risks, like the Asset Group mask dispute, could drain resources further.
10-Q
Q2 FY2025 results
Dalrada Financial's Q2 FY2025 revenues fell 28.5% y/y to $3.1M, driven by a 38.6% drop in Genefic's pharmacy sales amid working capital constraints, yet Dalrada Climate Technology surged 67.5% y/y to $1.1M on stronger construction projects. Gross profit climbed 87.3% y/y to $835K, lifting margins to 26.8% from 10.2%, while operating loss narrowed 12.6% y/y to $5.1M. Net loss eased to $6.7M ($0.07 per diluted share) from $7.0M ($0.08), with the gap to operating loss tied to $1.0M interest expense and $748K other costs. Cash dwindled to $140K, offset by $4.5M financing inflows mainly from related-party notes, pushing total debt to $8.1M; free cash flow not disclosed in the 10-Q. Acquired Grand Entrances in August 2024 for $100 cash plus $211K contingent consideration, adding $185K goodwill to integrate with construction pipelines. Ongoing litigation risks, like the Asset Group mask contract dispute, could strain resources further. Losses persist.
CRAI
CRA International,Inc.
202.19+3.00
DAIC
CID HoldCo, Inc.
1.64-0.02
DGNX
Diginex Limited
6.60-0.54
FCN
FTI Consulting, Inc.
170.87+0.28
HURN
Huron Consulting Group Inc.
179.14+0.74
HYDTF
Hydreight Technologies Inc
3.10-0.06
ICFI
ICF International, Inc.
87.68+0.97
ROMA
Roma Green Finance Limited
2.33-0.10
SBC
SBC Medical Group Holdings Inco
4.10+0.01
ZGM
Zenta Group Company Limited
2.39-0.10